Also known as آسٹیوپوروسس مینجمنٹ
General Physician
MBBS, FRACGP (Australia), Professional Certificate in Women Helath (Australia)
General Physician
MBBS, FRACGP (Australia), Professional Certificate in Women Helath (Australia)
Internal Medicine Specialist
M.B.B.S, F.C.P.S.(Medicine), M.R.C.P (Glasgow)
Internal Medicine Specialist
M.B.B.S, F.C.P.S.(Medicine), M.R.C.P (Glasgow)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP-UK, MACP (USA), Dip in Endocrinology UKAP (UK)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP-UK, MACP (USA), Dip in Endocrinology UKAP (UK)
Gastroenterologist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
MBBS, MRCP (IRELAND)
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
MBBS, MRCP (Ireland), MRCP (Glasgow)
Internal Medicine Specialist
MBBS, MRCP (Ireland), MRCP (Glasgow)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP1
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures